Endocrine oncology

A Comparison of the Predictive Value of International Medullary Thyroid Carcinoma Grading System (IMTCGS) With That of Other Risk Factors in a Chinese Medullary Thyroid Carcinoma Cohort

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

In this Chinese MTC cohort, IMTCGS was a powerful predictor of disease-specific death, while postoperative calcitonin was a powerful predictor of structural recurrence.

Study context

Population
Medullary thyroid carcinoma (MTC) patients undergoing initial surgery, January 2004–June 2023, Chinese cohort
Participants
137 patients
Exposure
IMTCGS high vs low grade and other risk factors for progression-free survival (PFS) and disease-specific survival (DSS)
Outcome
PFS and DSS; predictive value of IMTCGS vs other risk factors
Methodological detailsHistologic features reviewed by two pathologists
  • Histologic features reviewed by two pathologists

Main finding

As reported in the abstract

IMTCGS, TNM stage, postoperative calcitonin, postoperative CEA and vascular invasion associated with PFS (Kaplan-Meier)
all p < 0.05
Postoperative calcitonin: only independent predictor of PFS (multivariate), HR
1.002, p = 0.002
AUC for structural recurrence, postoperative calcitonin vs IMTCGS (Delong's test)
0.90 vs. 0.64, p = 0.002
IMTCGS, TNM stage and vascular invasion associated with DSS (Kaplan-Meier)
p < 0.05
IMTCGS: only independent predictor of DSS (multivariate), HR
11.23, p = 0.05
AUC of IMTCGS for disease-specific death
0.81 (p = 0.01)

Observational data: associations, not effects.

Further findings

Events

Local recurrence
14/134 (10.45%)
Distant metastasis
3/134 (2.24%)
Disease-specific death
6/137 (4.38%)

Original publication

A Comparison of the Predictive Value of International Medullary Thyroid Carcinoma Grading System (IMTCGS) With That of Other Risk Factors in a Chinese Medullary Thyroid Carcinoma Cohort. Clin Endocrinol (Oxf). Published 3 January 2025. doi:10.1111/cen.15195

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.